PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Orla Mining Ltd. (ORLA)
11.070.67 (6.44%)
10.50 - 11.12
3.81 - 12.83
1.80M / 1.60M (Avg.)
158.14 | 0.07
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
31.36%
EBIT growth 75-90% of ITRG's 37.32%. Bill Ackman would push for cost reforms or better product mix to narrow the gap.
31.36%
Operating income growth at 75-90% of ITRG's 37.32%. Bill Ackman would demand a plan to enhance operating leverage.
18.69%
Net income growth under 50% of ITRG's 314.20%. Michael Burry would suspect the firm is falling well behind a key competitor.
19.08%
EPS growth under 50% of ITRG's 314.41%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
19.08%
Diluted EPS growth under 50% of ITRG's 314.41%. Michael Burry would worry about an eroding competitive position or excessive dilution.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-17.98%
Negative OCF growth while ITRG is at 748.66%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-17.98%
Negative FCF growth while ITRG is at 748.66%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-21.25%
Negative 10Y net income/share CAGR while ITRG is at 0.00%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-21.25%
Negative 5Y net income/share CAGR while ITRG is 0.00%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-21.25%
Negative 3Y CAGR while ITRG is 0.00%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
44.00%
Equity/share CAGR of 44.00% while ITRG is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
44.00%
Equity/share CAGR of 44.00% while ITRG is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
44.00%
Equity/share CAGR of 44.00% while ITRG is zero. Bruce Berkowitz sees if minor gains can snowball into a bigger lead soon.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
154.86%
AR growth of 154.86% while ITRG is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
No Data
No Data available this quarter, please select a different quarter.
-2.43%
Negative asset growth while ITRG invests at 0.00%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-2.44%
We have a declining book value while ITRG shows 0.00%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-30.97%
We cut SG&A while ITRG invests at 5.81%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.